$380.03
3.570.95%
al cierre: Aug 21, 5:00 PM EST
$380.03
N/A
After hour: Aug 21, 4:00 PM EST
Bio-Rad Laboratories Inc
BIONYSE
Bio-Rad Laboratories Earnings & Forecasts
Bio-Rad Laboratories (BIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Bio-Rad Laboratories Guidance
Bio-Rad Laboratories (BIO) publicĆ³ su Ćŗltima previsiĆ³n de agosto 4, 2026 para fiscal year 2026. La compaƱĆa estimĆ³ ingresos en un rango de $2.51B - $2.6B para el perĆodo.
En comparaciĆ³n con la previsiĆ³n anterior, Bio-Rad Laboratories mantenido redujo su previsiĆ³n de ingresos desde un rango anterior de $2.51B - $2.6B.
Bio-Rad Laboratories ha emitido 16 actualizaciones de orientaciĆ³n entre el octubre 27, 2022 y el agosto 4, 2026. During this period, the company raised its outlook 3 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.86 | $2.14 | $2.65 | $2.08 |
| Actual | $2.62 | $1.89 | $2.51 | $2.26 |
| Surprise | +40.9% | -11.7% | -5.28% | +8.65% |
| Revenue | ||||
| Estimate | $630.7M | $587.4M | $689.9M | $651.3M |
| Actual | $651.0M | $592.1M | $693.2M | $653.0M |
| Surprise | +3.23% | +0.80% | +0.48% | +0.25% |
Analyst Estimates ā Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $2.31 | $2.84 | $2.22 |
| Revenue | |||
| Consensus | $652.9M | $693.6M | ā |